Declared technologies base

TRANSFER OF INNOVATIONAL TECHNOLOGIES

MEANS FOR CELL THERAPY


Purpose of the development: The tool can be used in institutions of the health care system for the treatment of human diseases of various origins.

Recommended application field: The medicine.

Advantages over analogues: There aren t domestic analogues. Compared to foreign drugs, it is cheaper to obtain and use cells from the umbilical cord to meet all moral and ethical standards and is non-invasive and safe. The drug can be used as an allogeneic or autologous material for systemic and topical use.

The development stage readiness: tested in laboratory condition

Description of the development:
()
A developed laboratory protocol for the production and cultivation of mesenchymal stem cells (MSCs) of human umbilical cord to the stage of their use in cell therapy. The effectiveness of the tool is shown in pilot animal studies.

corresponds technical description
Guarantees stable results getting

Possibility of transfer abroad:
Technological document's sale
Combinated reduction to industrial level

Photo

Country Ukraine

For additional information turn to:
E-mail: gal@uintei.kiev.ua

or fill out the form:
Organization name :
Address :
Settlement account :
Bank :
MFO :
OKPO code :

Scientific organization tutor's data :
Surname :
Name :
Patronymic :
Scientific degree :
Phone :
Fax :
E-mail :
Cooperation proposals (joint patent, joint enterprise, assembly sale and so on :
country: